Therapy of superficial fungal infection.
D000284:Administration, Oral; D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000008:administration & dosage / Q000009:adverse effects; D002177:Candidiasis / Q000188:drug therapy*; D002180:Candidiasis, Oral / Q000188:drug therapy; D003881:Dermatomycoses / Q000188:drug therapy*; D005437:Flucytosine / Q000627:therapeutic use; D006118:Griseofulvin / Q000627:therapeutic use; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use; D007275:Injections, Intravenous; D007654:Ketoconazole; D008825:Miconazole / Q000627:therapeutic use; D010879:Piperazines / Q000627:therapeutic use; D014005:Tinea / Q000188:drug therapy*; D014010:Tinea Versicolor / Q000188:drug therapy
D000935:Antifungal Agents; D007093:Imidazoles; D010879:Piperazines; D006118:Griseofulvin; D008825:Miconazole; D000666:Amphotericin B; D005437:Flucytosine; D007654:Ketoconazole